Preda, A., Montecucco, F., Carbone, F., Camici, G. G., Lüscher, T. F., Kraler, S., & Liberale, L. (2024). SGLT2 inhibitors: From glucose-lowering to cardiovascular benefits. Cardiovascular Research, 120(5), 443. https://doi.org/10.1093/cvr/cvae047
Chicago Style (17th ed.) CitationPreda, Alberto, Fabrizio Montecucco, Federico Carbone, Giovanni G. Camici, Thomas F. Lüscher, Simon Kraler, and Luca Liberale. "SGLT2 Inhibitors: From Glucose-lowering to Cardiovascular Benefits." Cardiovascular Research 120, no. 5 (2024): 443. https://doi.org/10.1093/cvr/cvae047.
MLA (9th ed.) CitationPreda, Alberto, et al. "SGLT2 Inhibitors: From Glucose-lowering to Cardiovascular Benefits." Cardiovascular Research, vol. 120, no. 5, 2024, p. 443, https://doi.org/10.1093/cvr/cvae047.